The Biomarkers in Depression Study (BIODEP) is the Consortium’s first clinical study, involving volunteers both with and without depression. The study is a collaboration between 5 UK universities and 4 pharmaceutical companies. The aim of the study is to find biomarkers for depression.
Biomarkers (Biological Markers) are “A naturally occurring molecule, gene, or characteristic by which a particular pathological or physiological process, disease, etc. can be identified.” For example, body temperature is a well-known biomarker for fever.
Below are some of the currently published articles from the BIODEP study:
Treatment-resistant depression and peripheral C-reactive protein
Dr Samuel Chamberlain, January 2019
Peripheral blood cell immunophenotyping reveals distinct subgroups of inflamed depression
Dr Mary-Ellen Lynall, November 2019